share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Joyner J. David

SEC announcement ·  Apr 3 17:05
Summary by Moomoo AI
On April 1, 2024, CVS Health EVP & President-Pharmacy Services, Joyner J. David, was granted 28,280 restricted shares of common stock, as per the latest filing with the SEC. The shares were acquired at no cost, indicating they were likely awarded as part of a compensation package. Following this transaction, David's direct holdings in CVS Health increased to a total of 44,241 shares. The grant is part of the company's long-term incentive plan for executives and is a common practice in aligning the interests of management with those of shareholders.
On April 1, 2024, CVS Health EVP & President-Pharmacy Services, Joyner J. David, was granted 28,280 restricted shares of common stock, as per the latest filing with the SEC. The shares were acquired at no cost, indicating they were likely awarded as part of a compensation package. Following this transaction, David's direct holdings in CVS Health increased to a total of 44,241 shares. The grant is part of the company's long-term incentive plan for executives and is a common practice in aligning the interests of management with those of shareholders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more